The Scientist reports that the FDA is changing its conflict-of-interest policy. In the past, if they wanted an interest waiver, the members of the organization's 32 advisory panels and committees would simply have to tell the FDA if they had any connections with a company that had a drug or medical device under FDA review, or with one of its competitors.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers have sequenced the northern white rhinoceros to gauge whether it could be brought back from the edge of extinction, the New York Times reports.

Bavaria expands its forensic genetic analyses to include DNA phenotyping, raising discrimination concerns.

Tufts University researchers found a role for miRNA in transmitting stress between generations, the Economist reports.

In Science this week: gut microbiome influences liver cancer growth, spread; and more.